|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/00 | |
| A61K 31/454 | |||
| A61K 45/06 | |||
| A61P 37/02 | |||
| A61P 37/04 | |||
| A61K 31/522 |
| (11) | Number of the document | 1924250 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05852555.1 |
| Date of filing the European patent application | 2005-11-30 | |
| (97) | Date of publication of the European application | 2008-05-28 |
| (45) | Date of publication and mention of the grant of the patent | 2017-01-04 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/043360 |
| Date | 2005-11-30 |
| (87) | Number | WO 2006/060507 |
| Date | 2006-06-08 |
| (30) | Number | Date | Country code |
| 631870 P | 2004-12-01 | US |
| (72) |
XU, Weiming, US
CORRAL, Laura, G., US
|
| (73) |
CELGENE CORPORATION,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | METHODS AND COMPOSITIONS COMPRISING IMMUNOMODULATORY COMPOUNDS FOR USE FOR THE TREATMENT OF IMMUNODEFICIENCY DISORDERS |
| METHODS AND COMPOSITIONS COMPRISING IMMUNOMODULATORY COMPOUNDS FOR USE FOR THE TREATMENT OF IMMUNODEFICIENCY DISORDERS |